Ownership history in Navalign, LLC · 19 quarters on record
This page tracks every 13F SEC filing in which Navalign, LLC reported a position in ALLOGENE THERAPEUTICS INC (ALLO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 49,398 | -10,467 | -17.5% | 0.02% | $68K | $1.37 |
| 2025 Q3 | UNCHANGED | 59,865 | — | 0% | 0.02% | $74K | $1.24 |
| 2025 Q2 | UNCHANGED | 59,865 | — | 0% | 0.02% | $68K | $1.13 |
| 2025 Q1 | UNCHANGED | 59,865 | — | 0% | 0.02% | $87K | $1.46 |
| 2024 Q4 | REDUCED | 59,865 | -15,500 | -20.6% | 0.04% | $128K | $2.13 |
| 2024 Q3 | UNCHANGED | 75,365 | — | 0% | 0.06% | $211K | $2.80 |
| 2024 Q2 | UNCHANGED | 75,365 | — | 0% | 0.06% | $176K | $2.33 |
| 2024 Q1 | UNCHANGED | 75,365 | — | 0% | 0.11% | $337K | $4.47 |
| 2023 Q4 | UNCHANGED | 75,365 | — | 0% | 0.08% | $242K | $3.21 |
| 2023 Q3 | UNCHANGED | 75,365 | — | 0% | 0.09% | $239K | $3.17 |
As of 2025 Q4 — sorted by position size